BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 9229319)

  • 1. Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.
    Fonseca E; Cruz JJ; Rodríguez CA; Gómez-Bernal A; Martín G; Sánchez P; Nieto A; Soria P; Vega MJ; Muñoz A; Pardal JL
    J Infus Chemother; 1996; 6(4):217-20. PubMed ID: 9229319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
    Chua DT; Sham JS; Au GK
    Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie.
    Mertens R; Granzen B; Lassay L; Gademann G; Hess CF; Heimann G
    Cancer; 1997 Sep; 80(5):951-9. PubMed ID: 9307197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive short cause chemotherapy followed by radiotherapy of locally advanced nasopharyngeal carcinoma.
    Zidan J; Kuten A; Robinson E
    Cancer; 1996 May; 77(10):1973-7. PubMed ID: 8640658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
    Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma.
    Maoleekoonpairoj S; Phromratanapongse P; Puttanuparp S
    J Med Assoc Thai; 1997 Dec; 80(12):778-84. PubMed ID: 9470331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.
    Ponzanelli A; Vigo V; Marcenaro M; Bacigalupo A; Gatteschi B; Ravetti JL; Corvò R; Benasso M
    Oral Oncol; 2008 Aug; 44(8):767-74. PubMed ID: 18061519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four days' continuous infusion of cisplatin-5-fluorouracil and short daily infusion of high-dose leucovorin as induction chemotherapy for locally advanced head and neck cancer.
    Cruz JJ; Fonseca E; Muñoz A; Nieto A; Gomez A; Garcia J; Martin G; Sanchez P; Panadero A; Garcia MJ
    J Infus Chemother; 1995; 5(3):125-8. PubMed ID: 8528969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
    Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
    Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
    Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
    Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.
    Rodriguez-Galindo C; Wofford M; Castleberry RP; Swanson GP; London WB; Fontanesi J; Pappo AS; Douglass EC
    Cancer; 2005 Feb; 103(4):850-7. PubMed ID: 15641027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma.
    Hareyama M; Sakata K; Shirato H; Nishioka T; Nishio M; Suzuki K; Saitoh A; Oouchi A; Fukuda S; Himi T
    Cancer; 2002 Apr; 94(8):2217-23. PubMed ID: 12001120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
    Johnson FM; Garden AS; Palmer JL; Shin DM; Morrison W; Papadimitrakopoulou V; Khuri F; Clayman G; Goepfert H; Ang KK; Hong WK; Glisson BS
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):717-24. PubMed ID: 16199307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
    J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.